Invenra has invented and developed a new screening platform PureProPep (P3) that enables unprecedented discovery opportunities in this space. The P3 Technology enables scientists to create and screen large, high-value, libraries against the cell-based phenotype assays preferred by pharmaceutical companies.

 

From poet and ski bum to disease fighter: Roland Green

JUDY NEWMAN jdnewman@madison.com Dec 2, 2018 CEO Roland Green, left, talks with scientist Daniel Gerhardt at Invenra's labs, 505 S. Rosa Road, where researchers are developing cancer-fighting drugs. Green majored in English literature then switched to environmental...